This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...

1Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, Florida. 2Immunology, Genome Regulation and Cell Signaling Program, The Wistar Institute, Philadelphia, Pennsylvania. 3Department of ...

1Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China. 2Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

1Department of Medical Imaging, College of Medicine, University of Saskatchewan, Saskatoon, Canada. Search for other works by this author on: 1Department of Medical Imaging, College of Medicine, ...

A 14-gene molecular assay can help identify patients with lung cancer who could benefit from chemotherapy after surgery, according to results of a study presented at the 2025 American Society of ...

The Blood Cancer Discovery Award for Outstanding Journal Article is awarded to the corresponding author of a peer-reviewed, original Research Article or Brief published within the previous two years ...

A single dose of the human papillomavirus vaccine confers protective immunity against infection on par with two doses, according to results from the NCI’s ESCUDDO trial, potentially making it easier ...

From molecules to medicine, from proteomics to prevention, the journals of the AACR cover the entire spectrum of cancer research. Please select the journal that is most appropriate for your manuscript ...

1Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. 2Division of Hematology/Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, Oregon. ...

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. Accept ...

Inavolisib (Itovebi; Genentech) boosted survival in patients with HR-positive, HER2-negative advanced breast cancer and extended the time they could wait before starting chemotherapy. In the phase III ...